Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Biopharma (CBIO) Non-cash Items (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Non-cash Items for 8 consecutive years, with $6.0 million as the latest value for Q1 2025.

  • For Q1 2025, Non-cash Items rose 16.29% year-over-year to $6.0 million; the TTM value through Mar 2025 reached $6.0 million, up 16.29%, while the annual FY2023 figure was $887696.0, 74.68% down from the prior year.
  • Non-cash Items hit $6.0 million in Q1 2025 for Crescent Biopharma, up from $5.0 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $6.0 million in Q1 2025 and bottomed at $1500.0 in Q1 2021.
  • Average Non-cash Items over 5 years is $2.7 million, with a median of $3.4 million recorded in 2022.
  • Year-over-year, Non-cash Items tumbled 99.95% in 2021 and then skyrocketed 104846.62% in 2022.
  • Crescent Biopharma's Non-cash Items stood at $4.9 million in 2021, then fell by 28.98% to $3.5 million in 2022, then tumbled by 74.68% to $887696.0 in 2023, then surged by 463.28% to $5.0 million in 2024, then rose by 19.04% to $6.0 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $6.0 million, $5.0 million, and $50000.0 for Q1 2025, Q3 2024, and Q2 2024 respectively.